Innovent and IASO Bio Enhance Strategic Collaboration in Cell Therapy
SAN FRANCISCO and SUZHOU, China, July 5, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology and other major diseases, and IASO Biotechnology ("IASO Bio"), a biopharmaceutical company engaged in discovering, developing, manufacturing, and marketing innovative cell therapies...
Biostar Pharma Announces FDA Clearance of the IND Application for a Phase 2 Study of Utidelone Injection (UTD1) in HER2- Breast Cancer Brain Metastasis
SAN FRANCISCO, July 5, 2024 /PRNewswire/ -- Biostar Pharma, Inc., the U.S. subsidiary of Beijing Biostar Pharmaceuticals Co., Ltd. (Biostar), which is a synthetic biology-driven biopharma company focusing on the development and commercialization of innovative oncology drugs, announced today that their core pipeline product Utidelone Injection (UTD1) had been granted to conduct a phase 2 study (BG01-2402) for...
Zhejiang Doer Biologics Completes Enrollment of the Phase 1b/2a Trial Evaluating DR10624 in Obese Subjects with Modest Hypertriglyceridemia
HANGZHOU, China, July 5, 2024 /PRNewswire/ -- Zhejiang Doer Biologics Co., Ltd. ("Doer Bio"), a clinical stage biopharmaceutical company developing innovative biotherapeutics for metabolic diseases and cancers, today announces that the company has completed the enrollment in the Phase 1b/2a trial evaluating DR10624 in obese subjects with modest hypertriglyceridemia in New...
Egg-White Rice – an Innovative Alternative Food Rich in Nutrients that Appeals to the Health Conscious
BANGKOK, July 5, 2024 /PRNewswire/ -- Chula Faculty of Allied Health Sciences has launched a ready-to-eat flourless rice innovation made from egg whites, branded "eggyday". This product is low in calories, filled with good-quality protein, high in calcium, complete with dietary fibers, and free of gluten. It is suitable for health-conscious people trying to control their weight, the elderly,...
Bloomage Chairperson Zhao Yan Speaks on Sustainable Innovation at the 2024 Summer Davos Forum
PARSIPPANY, N.J., July 4, 2024 /PRNewswire/ -- Zhao Yan, Chairperson and CEO of Bloomage, attended the 15th Annual Meeting of the New Champions (Summer Davos Forum) organized by the World Economic Forum to offer insights on navigating the current uncertainties in the global economy. This year's Summer Davos Forum focused on "The New Frontiers of Future Growth."...
Neurosurgeon Dr. Teo Kejia Shares Advancements in Brain Surgery Techniques for Optimal Patient Care
SINGAPORE, July 4, 2024 /PRNewswire/ -- Conventional brain surgery involves an invasive method of removing part of the skull to access the brain for treatments. It is used to treat various conditions, including brain tumours, aneurysms, epilepsy, and traumatic brain injuries. While this type of surgery can be life-saving and provide significant benefits, it also has several downsides and...
Seizing a Threefold Victory! PM-International Malaysia Wins Three Awards at the Asia Pacific Enterprise Awards 2024 Malaysia
SINGAPORE, July 4, 2024 /PRNewswire/ -- The Asia Pacific Enterprise Awards (APEA) 2024 Malaysia culminated in a spectacular celebration of innovation, perseverance, and inclusive growth on 7th June at the InterContinental Kuala Lumpur, Malaysia. Organized annually in 16 markets by regional NGO Enterprise Asia, the Awards presents Asia's largest award networking platform. Themed "Celebrating Inclusive Entrepreneurship", the Awards aims...
LOTTE BIOLOGICS Holds Groundbreaking for Songdo Bio Campus
Plans to Join the Ranks of the TOP 10 Global CDMOs, Heralding a New Era in the Global CDMO Landscape SEOUL, South Korea, July 4, 2024 /PRNewswire/ -- In a landmark event signaling its ambitious foray into the biopharmaceutical sector, LOTTE BIOLOGICS, under the leadership of CEO Richard W. Lee, held...
Docquity accelerates growth for pediatric multivitamin distributor Green Nature Farm in Indonesia
GNF leverages Docquity's Awareness to Advocacy (A2A) Program and local partnerships to build HCP relationships and expand distribution across Indonesia over seven years GNF hits 20% of its overall doctor outreach target in just one month since the partnership started JAKARTA, Indonesia, July 4, 2024 /PRNewswire/ -- Docquity, Southeast Asia's...
Ascentage Pharma Received US$100 Million Option Payment from Takeda
ROCKVILLE, Md. and SUZHOU, China, July 4, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to the Exclusive Option Agreement with Takeda for the third-generation BCR-ABL inhibitor olverembatinib (HQP1351),...
